Choosing between NAD+ IV therapy and glutathione IV therapy isnt straightforward
Boost your cell protection, aid your liver in detox, help improve cardiovascular health, brain & immune function
The Mounjaro KwikPen is a multi-dose pen. It contains 2.4mL of solution with 50mg of Tirzepatide total, which is pre-calibrated to deliver exactly 4 separate weekly doses of 12.5mg (0.6mL each)
Side Effects & Safety Nausea most common (~33% at high doses), dose-dependent, typically improves over time GI effects vomiting, diarrhea, constipation, slowed gastric emptying (GLP-1 class effects) Heart rate changes transient increases observed in trials, peaked at 24 weeks then declined Injection site reactions mild redness or irritation Gallbladder risk rapid weight loss increases gallstone risk (common with any rapid weight loss method) No major safety signals in 48-week trial up to 12 mg weekly At community doses (1.5 mg/week), side effects are notably milder than high-dose trial groups Dosage Chart This dosage chart consolidates the doses reported in published Phase 2 trials and self-reported community protocols, expressed in milligrams (mg) and converted to units on a standard 100-unit / 1mL insulin syringe
While we know these medications are effective, we dont have enough data to paint a clear picture of how GLP-1s can impact overall long-term healthespecially for those with a variety of health conditions that may interact differently with these drugs
